Inhibikase Therapeutics, Inc. (IKT) stock
IKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.38+0.00 (0.00%)
Close on Nov 18, 2026Market cap $192.56MP/E –Yield –
Inhibikase Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Inhibikase Therapeutics's market cap was $215.21M on Nov 11, 2026, against $113.71M a year earlier. Over the last 5 years it ranged from $4.69M to $305.00M, with a median of $23.10M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $215.21M | +40.3% |
| 2025 | Dec 31, 2025 | $153.36M | +532.2% |
| 2024 | Dec 31, 2024 | $24.26M | +256.3% |
| 2023 | Dec 29, 2023 | $6.81M | -46.0% |
| 2022 | Dec 30, 2022 | $12.61M | -65.9% |
| 2021 | Dec 31, 2021 | $36.95M | – |
See a number that looks wrong?